[STEMI network Essen--results after 1 year].

Area of Science:

• Cardiology
• Public Health
• Health Services Research

Background:

• The "Herzinfarktverbund Essen" network was established to standardize ST elevation myocardial infarction (STEMI) care in Essen.
• The primary goal was rapid reperfusion of the infarcted artery via direct transfer to a cardiac catheterization lab.

Purpose of the Study:

• To evaluate the effectiveness of a standardized STEMI treatment strategy.
• To identify factors influencing mortality and restenosis in STEMI patients.

Main Methods:

• Analysis of 1-year follow-up data from the "Herzinfarktverbund Essen" network.
• Assessment of mortality rates and influencing factors, including patient demographics, clinical status, and interventional parameters.
• Comparison of restenosis rates between bare-metal stents (BMS) and drug-eluting stents (DES).

Main Results:

• A low 1-year mortality rate of 11.2% was observed, with 7.6% in-hospital mortality.
• Mortality was significantly associated with age, prehospital cardiovascular stability, left ventricular damage, TIMI flow post-intervention, and "puncture-to-balloon" time.
• Drug-eluting stents (DES) demonstrated a lower restenosis rate compared to bare-metal stents (BMS).
• Recurrent myocardial infarction rates (STEMI and NSTEMI) were low at 1.8% and 1.7%, respectively.

Conclusions:

• The standardized treatment strategy for STEMI patients in an urban setting was successfully implemented.
• The network demonstrated effective guideline adherence and improved patient outcomes.
• Age, prehospital status, infarct severity, and intervention timeliness are critical determinants of STEMI patient survival.